FDA to Reevaluate Safety of Parkinson ’s Psychosis Drug
Amidst reports of safety concerns involving pimavanserin, a drug approved to treat psychosis symptoms among patients with Parkinson ’s disease, the Food and Drug Administration stated it has begun reassessing the safety of the drug.
Source: Caring for the Ages - Category: Health Management Authors: Brian Ellis Source Type: news